Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited
FormerlyTrinity Laboratories (1959–1971)
Company typePublic
ISININE685A01028
IndustryPharmaceuticals
Founded1959; 65 years ago (1959)
FounderU. N. Mehta
HeadquartersAhmedabad, Gujarat, India
Area served
Worldwide
Key people
Products
RevenueIncrease ₹10,728 crore (US$1.3 billion) (FY24)[2]
Increase ₹3,368 crore (US$400 million) (FY24)[2]
Increase ₹1,656 crore (US$200 million) (FY24)[2]
Number of employees
12,881 (2020)[3]
ParentTorrent Group
Websitewww.torrentpharma.com

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics.[4]

  1. ^ Rajan, Sreejith (7 February 2024). "Torrent Pharma says company at a new stage of profitability". The New Indian Express. Retrieved 28 May 2024.
  2. ^ a b c "Torrent Pharma announces Q4 FY24 results" (PDF). Torrent Pharmaceuticals. Retrieved 28 May 2024.
  3. ^ "Torrent Pharmaceuticals Ltd. Financial Statements". moneycontrol.com.
  4. ^ "Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore". Medical Dialogues. 23 July 2019.